On this poster you will learn how we converted an adherent, serum-dependent hCK cell line into a serum-free suspension cell line over a period of 10 months without changing its engineered properties.
Now this modified serum-free suspension MDCK cell line provides an ideal platform for the isolation of human influenza viruses from clinical samples and the production of influenza vaccines on an industrial scale.
Download here
You are currently viewing a placeholder content from X. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information